trending Market Intelligence /marketintelligence/en/news-insights/trending/z26ZlBrF31CWcbbr_qZsiQ2 content esgSubNav
In This List

Epizyme CFO to step down

Case Study

Identifying PPE Suppliers During the Pandemic


Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage


COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021


Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Epizyme CFO to step down

Epizyme Inc. said Andrew Singer will step down as CFO and executive vice president of finance and administration at the end of August to pursue other business opportunities.

Susan Graf, chief business officer, will take over the responsibility for the finance organization going forward, including Epizyme's financial reporting and analysis group.

Epizyme plans to add a senior vice president of finance beginning in September and has secured the professional finance consulting services of Danforth Advisors during this transition.